Inflammatory Bowel Diseases Clinical Trials

106 recruiting

Inflammatory Bowel Diseases Trials at a Glance

110 actively recruiting trials for inflammatory bowel diseases are listed on ClinicalTrialsFinder across 6 cities in 53 countries. The largest study group is Not Applicable with 31 trials, with the heaviest enrollment activity in London, New York, and Boston. Lead sponsors running inflammatory bowel diseases studies include Massachusetts General Hospital, Tanta University, and University of Michigan.

Browse inflammatory bowel diseases trials by phase

Treatments under study

About Inflammatory Bowel Diseases Clinical Trials

Looking for clinical trials for Inflammatory Bowel Diseases? There are currently 106 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Bowel Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Bowel Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 110 trials

Recruiting
Phase 2

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
University of Birmingham58 enrolled5 locationsNCT06286709
Recruiting
Not Applicable

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
University of Michigan68 enrolled1 locationNCT06094608
Recruiting

Predictors of Prognosis in IBD Patients

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Seoul National University Bundang Hospital100 enrolled1 locationNCT05653011
Recruiting
Phase 2

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

ColitisInflammatory Bowel DiseasesUlcerative Colitis
Spyre Therapeutics, Inc.645 enrolled175 locationsNCT07012395
Recruiting

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+9 more
Seattle Children's Hospital200 enrolled1 locationNCT06315179
Recruiting
Phase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled215 locationsNCT06226883
Recruiting
Phase 3

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Inflammatory Bowel DiseasesCrohn's DiseaseUlcerative Colitis+1 more
Eli Lilly and Company150 enrolled66 locationsNCT04844606
Recruiting

Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study

Inflammatory Bowel Diseases
Nanfang Hospital, Southern Medical University420 enrolled1 locationNCT07539727
Recruiting

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis, Pediatric
University of North Carolina, Chapel Hill1,100 enrolled4 locationsNCT07198113
Recruiting
Phase 2

Pentoxifylline in Patients With Ulcerative Colitis

Inflammatory Bowel Diseases
Ihab Elsayed Hassan60 enrolled1 locationNCT07349472
Recruiting

A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea

Inflammatory Bowel Diseases
Janssen Korea, Ltd., Korea8,000 enrolled1 locationNCT07520747
Recruiting
Not Applicable

Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial

Inflammatory Bowel DiseasesCrohn's Disease Relapse
Shanghai Institute of Acupuncture, Moxibustion and Meridian106 enrolled1 locationNCT06553053
Recruiting

Therapeutic Endpoint in Pediatric IBD Conditions

Inflammatory Bowel Diseases
Children's National Research Institute60 enrolled1 locationNCT06065228
Recruiting
Not Applicable

Heart Rate Variability and Inflammatory Bowel Disease

Inflammatory Bowel Diseases
Emory University128 enrolled3 locationsNCT06537258
Recruiting

Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases

Inflammatory Bowel DiseasesSclerodermaVasculitis+2 more
University Hospital, Toulouse3,000 enrolled1 locationNCT05251415
Recruiting
Phase 2Phase 3

Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease

Inflammatory Bowel Diseases
Mostafa Bahaa50 enrolled1 locationNCT05986136
Recruiting
Not Applicable

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease

Inflammatory Bowel Diseases
NYU Langone Health150 enrolled1 locationNCT06309017
Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Inflammatory Bowel DiseasesHeart DiseasesAutoimmune Disease+5 more
University of Chicago1,200 enrolled1 locationNCT01280825
Recruiting
Not Applicable

Fermented Food-Supplemented Diet in Ulcerative Colitis

Inflammatory Bowel DiseasesUlcerative ColitisDiet Modification
Stanford University21 enrolled1 locationNCT04401605
Recruiting
Early Phase 1

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
Stanford University15 enrolled1 locationNCT05912387